Overview


According to FutureWise analysis the market for Amlodipine Besylate is expected to register a CAGR of 3.80% from 2023-2031.

Amlodipine besylate is a medication that plays a crucial role in managing certain cardiovascular conditions. This is mainly utilized to address hypertension, a condition where blood pressure levels are high and can have effect on the heart and blood vessels. Additionally, it is employed in the treatment of angina, a type of chest pain that happens when the heart doesn't receive an adequate supply of oxygen-rich blood.The medication operates through its effect on calcium channels, which are responsible for controlling the flow of calcium ions into muscle cells, particularly those in blood vessels and the heart. By blocking these calcium channels, amlodipine besylate reduces the passage of calcium ions into smooth muscle cells lining blood vessels and the heart. This results in relaxation and dilation of the blood vessels, leading to lowered resistance in the vessels and subsequently decreasing blood pressure. Moreover, the heart experiences reduced contractility, which alleviates the workload on the heart muscle and helps relieve symptoms of angina.

Amlodipine besylate is most commonly administered in the form of oral tablets, usually taken once daily to maintain a consistent level of the medication in the bloodstream. It can be taken with or without food, as directed by a healthcare provider. While its main effects are beneficial in managing hypertension and angina, the medication may have side effects, including dizziness, swelling in the ankles or feet, headaches, and flushing. However, serious side effects are relatively uncommon.It is essential for individuals considering or using amlodipine besylate to engage in open discussions with their healthcare providers. Certain medical conditions, such as liver disorders or heart conditions, might necessitate adjustments to the medication's dosage or close monitoring.

FutureWise Market Research has published a report that provides an insightful analysis of Amlodipine Besylate Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Amlodipine Besylate Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Aurobindo Pharma
  • MACLEODS
  • Pfizer
  • Alkem Laboratories
  • Mylan
  • CR Pharmaceutical
  • Dr. reddy's Laboratories
  • Epic Pharma
  • Apotex
  • Wockhardt
  • Cipla
  • Hikma Pharmaceuticals
  • Oxford Pharm
  • Strides Pharma
  • Zydus Pharmaceuticals
  • Upsher-Smith Laboratories
  • Sun Pharmaceutical

(Note: The list of the major players will be updated with the latest market scenario and trends)

The pharmaceutical and healthcare sectors have undergone significant transformations in recent years, primarily driven by factors like the rising prevalence of diseases, advancements in medical technology, and substantial investments in research and development endeavors, which are expected to boost Amlodipine Besylate market growth. Notably, increased funding from both public and private sectors, along with burgeoning activity in drug discovery, have acted as catalysts for the expansion of market revenues. Moreover, the availability of cutting-edge technologies in developed and developing nations, coupled with enhancements in healthcare infrastructure and the growing adoption of rapid testing and point-of-care diagnostics, have further propelled market growth. Furthermore, the escalating requirement for home care settings, the emphasis on early diagnosis, and the rapid uptake of precision medicine have further energized market expansion. High blood pressure, a prevalent issue, can inflict substantial harm on critical body organs such as the brain, heart, blood vessels, and kidneys. If left untreated, it can give rise to severe health complications like heart attacks, heart failure, strokes, kidney dysfunction, and vision loss. For individuals with high blood pressure, maintaining a continuous regimen of amlodipine is crucial, even if they feel well. A key market trend revolves around the growing usage of amlodipine besylate across diverse treatment approaches, emerging as a pivotal driver of market dynamics. However, there exist challenges in the form of potential side effects on human health, which could potentially hinder the market's growth trajectory.

By Type

  • 2.5mg Tablets
  • 5mg Tablets
  • 10mg tablets

By Application

  • High Blood Pressure
  • Heart Diseases

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The growth of the amlodipine besylate market in this region is primarily attributed to the elevated prevalence of hypertension within the United States, driving an increasing demand for amlodipine besylate consumption. The United States stands as the dominant force in the region, significantly contributing to revenue generation, closely followed by Canada. The substantial investments made in the pharmaceutical sector play a pivotal role in propelling the growth trajectory. The presence of established pharmaceutical entities further amplifies this momentum. Additionally, the region faces a notable prevalence of heart failure cases, which prompts a heightened need for effective treatments like amlodipine besylate. The considerable economic burden associated with heart failure cases underscores the urgency to address these conditions, further supporting the expansion of the regional market. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Amlodipine Besylate Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Amlodipine Besylate Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amlodipine Besylate Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Amlodipine Besylate Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Amlodipine Besylate Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 2.5mg Tablets
        2. 5mg Tablets
        3. 10mg tablets

  • 8.   Amlodipine Besylate Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. High Blood Pressure
        2. Heart Diseases

  • 9.   North America Amlodipine Besylate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Amlodipine Besylate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Amlodipine Besylate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Amlodipine Besylate Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Aurobindo Pharma
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. MACLEODS
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Pfizer
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Alkem Laboratories
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Mylan
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. CR Pharmaceutical
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Dr. reddy's Laboratories
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Epic Pharma
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Apotex
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Wockhardt
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
         11. Cipla
          11.1. Company Overview
          11.2. Product Portfolio
          11.3. SWOT Analysis
          11.4. Financial Overview
          11.5. Strategic Overview
         12. Hikma Pharmaceuticals
          12.1. Company Overview
          12.2. Product Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
         13. Oxford Pharm
          13.1. Company Overview
          13.2. Product Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
         14. Strides Pharma
          14.1. Company Overview
          14.2. Product Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
         15. Zydus Pharmaceuticals
          15.1. Company Overview
          15.2. Product Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
         16. Upsher-Smith Laboratories
          16.1. Company Overview
          16.2. Product Portfolio
          16.3. SWOT Analysis
          16.4. Financial Overview
          16.5. Strategic Overview
         17. Sun Pharmaceutical
          17.1. Company Overview
          17.2. Product Portfolio
          17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients